LumiraDx Ltd
DelistedCIK 1685428fmd_0GX1S5P2XXM23AQVN1QR8GBGBJManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2019 to Jun 30, 2023, 7 periods
Latest annual · FY2022
Millions- Total revenues
- 254
- Gross profit
- (35)
- Operating income
- (321)
- Net income
- (448)
- Free cash flow
- (187)
Bulls and bears
Loading
News summary
An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.
AI-written
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2019 to FY2022
- +122.4%
LumiraDx Ltd financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Revenue | $254.5 million | $421.4 million | -39.6% | 20-F 2023-05-01 · proof |
| Gross profit | -$35.3 million | $151.5 million | -123.3% | 20-F 2023-05-01 · proof |
| Operating income | -$321.4 million | -$145.4 million | 20-F 2023-05-01 · proof | |
| Net income | -$447.8 million | -$100.9 million | 20-F 2023-05-01 · proof | |
| Cash from operating activities | -$162.1 million | -$134.6 million | 20-F 2023-05-01 · proof | |
| Free cash flow | -$187.1 million | -$240.9 million | 20-F 2023-05-01 · proof | |
| Total assets | $441 million | $644.8 million | -31.6% | 20-F 2023-05-01 · proof |
| Total liabilities | $546.4 million | $482.2 million | +13.3% | 20-F 2023-05-01 · proof |
| Cash and cash equivalents | $100 million | $132.1 million | -24.3% | 20-F 2023-05-01 · proof |
| Total debt | $366.6 million | $301.3 million | +21.6% | 20-F 2023-05-01 · proof |
- What was LumiraDx Ltd's revenue in fiscal 2022?
- LumiraDx Ltd reported revenue of $254.5 million for fiscal 2022 (the year ended Dec 31, 2022), against $421.4 million the year before (-39.6%). Source: the 20-F filed with the SEC on May 1, 2023. SEC
- What was LumiraDx Ltd's gross profit in fiscal 2022?
- LumiraDx Ltd reported gross profit of -$35.3 million for fiscal 2022 (the year ended Dec 31, 2022), against $151.5 million the year before (-123.3%). Source: the 20-F filed with the SEC on May 1, 2023. SEC
- What was LumiraDx Ltd's operating income in fiscal 2022?
- LumiraDx Ltd reported operating income of -$321.4 million for fiscal 2022 (the year ended Dec 31, 2022), against -$145.4 million the year before. Source: the 20-F filed with the SEC on May 1, 2023. SEC
- What was LumiraDx Ltd's net income in fiscal 2022?
- LumiraDx Ltd reported net income of -$447.8 million for fiscal 2022 (the year ended Dec 31, 2022), against -$100.9 million the year before. Source: the 20-F filed with the SEC on May 1, 2023. SEC
- What was LumiraDx Ltd's cash from operating activities in fiscal 2022?
- LumiraDx Ltd reported cash from operating activities of -$162.1 million for fiscal 2022 (the year ended Dec 31, 2022), against -$134.6 million the year before. Source: the 20-F filed with the SEC on May 1, 2023. SEC
- What was LumiraDx Ltd's free cash flow in fiscal 2022?
- LumiraDx Ltd reported free cash flow of -$187.1 million for fiscal 2022 (the year ended Dec 31, 2022), against -$240.9 million the year before. Source: the 20-F filed with the SEC on May 1, 2023. SEC
- What are LumiraDx Ltd's total assets?
- As of Dec 31, 2022, LumiraDx Ltd reported total assets of $441 million, against $644.8 million a year earlier (-31.6%). Source: the 20-F filed with the SEC on May 1, 2023. SEC
- What are LumiraDx Ltd's total liabilities?
- As of Dec 31, 2022, LumiraDx Ltd reported total liabilities of $546.4 million, against $482.2 million a year earlier (+13.3%). Source: the 20-F filed with the SEC on May 1, 2023. SEC
- What are LumiraDx Ltd's cash and cash equivalents?
- As of Dec 31, 2022, LumiraDx Ltd reported cash and cash equivalents of $100 million, against $132.1 million a year earlier (-24.3%). Source: the 20-F filed with the SEC on May 1, 2023. SEC
- What is LumiraDx Ltd's total debt?
- As of Dec 31, 2022, LumiraDx Ltd reported total debt of $366.6 million, against $301.3 million a year earlier (+21.6%). Source: the 20-F filed with the SEC on May 1, 2023. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1685428&period_type=annual&limit=5"Information only, not investment advice.